Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00523367 · ClinicalTrials.gov registry record · NA
COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00523367: Clinical Trial NA study, sponsored by University of Florida.
NCT00523367 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00523367, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine which COPD patients have GERD and if COPD patients with GERD treated with high dose lansoprazole for 1 year decreases the frequency of COPD exacerbations compared to the previous year without treatment.
Primary Outcome
The number of participants who have Gastro Esophageal Reflux Disease after one year of treatment.
Interventions
- PROCEDURE 24 hour pH testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-10 |
| Phase | NA |
Why NCT00523367 stopped before completion
NCT00523367 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which 24 hour pH testing is the first listed.
NCT00523367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00523367 about?
NCT00523367 is a clinical study titled "COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI". The purpose of this study is to determine which COPD patients have GERD and if COPD patients with GERD treated with high dose lansoprazole for 1 year decreases the frequency of COPD exacerbations compared to the previous year without treatment.
What is the current status of trial NCT00523367?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2007-08. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00523367?
The interventions under investigation include: 24 hour pH testing (PROCEDURE).
Who is sponsoring clinical trial NCT00523367?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00523367's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia